1 - 10 out of 113Page size: 10
  1. 2023

  2. Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors

    Martens, A. W. J., Kavazovi?, I., Krapi?, M., Pack, S. M., Arens, R., Jongejan, A., Moerland, P. D., Eldering, E., van der Windt, G. J. W., Wensveen, F. M., Peters, F. S. & Kater, A. P., Mar 2023, In: Leukemia. 37, 3, p. 606-616 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Osteopontin associates with brain TRM-cell transcriptome and compartmentalization in donors with and without multiple sclerosis

    Hsiao, C-C., Engelenburg, H. J., Jongejan, A., Zhu, J., Zhang, B., Mingueneau, M., Moerland, P. D., Huitinga, I., Smolders, J. & Hamann, J. R., 20 Jan 2023, In: iScience. 26, 1, 105785.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. 2022

  5. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

    Claireaux, M., Caniels, T. G., de Gast, M., Han, J., Guerra, D., Kerster, G., van Schaik, B. D. C., Jongejan, A., Schriek, A. I., Grobben, M., Brouwer, P. J. M., van der Straten, K., Aldon, Y., Capella-Pujol, J., Snitselaar, J. L., Olijhoek, W., Aartse, A., Brinkkemper, M., Bontjer, I., Burger, J. A., & 13 othersPoniman, M., Bijl, T. P. L., Torres, J. L., Copps, J., Martin, I. C., de Taeye, S. W., de Bree, G. J., Ward, A. B., Sliepen, K., van Kampen, A. H. C., Moerland, P. D., Sanders, R. W. & van Gils, M. J., 1 Dec 2022, In: Nature communications. 13, 1, 4539.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma

    Leeksma, A. C., Derks, I. A. M., Garrick, B., Jongejan, A., Colombo, M., Bloedjes, T., Trowe, T., Leisten, J. C., Howarth, M., Malek, M., Mortensen, D. S., Blease, K., Groza, M. C., Narla, R. K., Loos, R., Kersten, M-J., Moerland, P. D., Guikema, J. E. J., Kater, A. P., Eldering, E., & 1 othersFilvaroff, E. H., 18 Nov 2022, (E-pub ahead of print) In: Molecular oncology.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study

    Leerink, J. M., Feijen, E. A. M., Moerland, P. D., de Baat, E. C., Merkx, R., van der Pal, H. J. H., Tissing, W. J. E., Louwerens, M., van den Heuvel-Eibrink, M. M., Versluys, A. B., Asselbergs, F. W., Sammani, A., Teske, A. J., van Dalen, E. C., van der Heiden-van der Loo, M., van Dulmen-den Broeder, E., de Vries, A. C. H., Kapusta, L., Loonen, J., Pinto, Y. M., & 3 othersKremer, L. C. M., Mavinkurve-Groothuis, A. M. C. & Kok, W. E. M., 19 Jul 2022, In: Journal of the American Heart Association. 11, 14, p. e025935 e025935.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages' transition into a pro-inflammatory state

    Bosmans, L. A., van Tiel, C. M., Aarts, S. A. B. M., Willemsen, L., Baardman, J., van Os, B. W., den Toom, M., Beckers, L., Ahern, D. J., Levels, J. H. M., Jongejan, A., Moerland, P. D., Verberk, S. G. S., van den Bossche, J., de Winther, M. M. P. J., Weber, C., Atzler, D., Monaco, C., Gerdes, N., Shami, A., & 1 othersLutgens, E., 19 May 2022, (E-pub ahead of print) In: Cardiovascular research.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Gamma-H2AX Foci Decay Ratio as a Stronger Predictive Factor of Late Radiation Toxicity Than Dose-Volume Parameters in a Prospective Cohort of Prostate Cancer Patients

    Nuijens, A. C., Oei, A. L., van Oorschot, B., Visser, J., van Os, R. M., Moerland, P. D., Franken, N. A. P., Rasch, C. R. N. & Stalpers, L. J. A., 1 Jan 2022, In: International Journal of Radiation Oncology Biology Physics. 112, 1, p. 212-221 10 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. 2021

  11. Core circadian clock genes Per1 and Per2 regulate the rhythm in photoreceptor outer segment phagocytosis

    Milićević, N., Ait-Hmyed Hakkari, O., Bagchi, U., Sandu, C., Jongejan, A., Moerland, P. D., ten Brink, J. B., Hicks, D., Bergen, A. A. & Felder-Schmittbuhl, M-P., 1 Jul 2021, In: FASEB journal. 35, 7, e21722.

    Research output: Contribution to journal › Article › Academic › peer-review

  12. 2020

  13. Time-resolved profiling reveals atf3 as a novel mediator of endocrine resistance in breast cancer

    Borgoni, S., Sofyalı, E., Soleimani, M., Wilhelm, H., Müller-Decker, K., Will, R., Noronha, A., Beumers, L., Verschure, P. J., Yarden, Y., Magnani, L., van Kampen, A. H. C., Moerland, P. D. & Wiemann, S., 2 Oct 2020, In: Cancers. 12, 10, p. 1-19 19 p., 2918.

    Research output: Contribution to journal › Article › Academic › peer-review

  14. Core-clock genes Period 1 and 2 regulate visual cascade and cell cycle components during mouse eye development

    Bagchi, U., Gegnaw, S. T., Milićević, N., Sandu, C., ten Brink, J. B., Jongejan, A., Hicks, D., Moerland, P. D., Felder-Schmittbuhl, M-P. & Bergen, A. A., 1 Oct 2020, In: Biochimica et Biophysica Acta-Gene Regulatory Mechanisms. 1863, 10, 194623.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 73963